Introducing APIs to Silicone & Controlling Elution Rates
Our Trelleborg Healthcare & Medical experts have placed an emphasis on serving our partners developing drug-eluting devices and implantable drug delivery systems because of the potential these technologies have to provide innovative therapies for patients.
In an effort to build confidence in these therapeutic forms our team presents the information that has led to our excitement about the technology as well as a detailed recap of experiments we’ve conducted along with a summary of learnings we’ve gathered as a result.Key Takeaways:
An understanding of the market trends supporting increased developmentFamiliarity with the early uses of drug elution as well as our expectations on where it will goExcipient materials used as well as the manufacturing methods that can be employedA detailed breakdown of multiple ways APIs can be introduced to siliconeA better view of alternative methods for introducing APIs to silicone via several case studies presented<
Trelleborg Healthcare & Medical
-
FR
-
2021On CPHI since
-
2Certificates
-
5000+Employees
Other Content from Trelleborg Healthcare & Medical ()
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance